Cellectar Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CLRB Nasdaq 2836 www.cellectar.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cellectar Biosciences, Inc.

Cellectar Biosciences Announces Closing of $6.9 Million Underwritten Public Offering, including Full Exercise of Over-Allotment Option - Jul 2nd, 2025 2:15 pm
Top Midday Decliners - Jul 1st, 2025 12:27 pm
Cellectar Biosciences Announces Pricing of $6 Million Underwritten Public Offering - Jul 1st, 2025 7:25 am
Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement - Jun 26th, 2025 6:05 am
Cellectar Biosciences Submits Phase 1b Clinical Trial Protocol to US Food and Drug Administration for CLR 125 to Treat Triple-Negative Breast Cancer (TNBC) - Jun 24th, 2025 6:30 am
Cellectar Biosciences Announces One-for-Thirty Reverse Stock Split - Jun 18th, 2025 2:30 pm
Cellectar Biosciences Provides Update on CLOVER-2 Phase 1 Clinical Trial of Iopofosine I 131 in Pediatric Patients with Relapsed/Refractory High-Grade Glioma - Jun 11th, 2025 6:05 am
Are Medical Stocks Lagging Anixa Biosciences (ANIX) This Year? - Jun 5th, 2025 7:40 am
Cellectar Biosciences Enters into Common Stock Agreements to Raise $2.5 Million Priced at Market Under Nasdaq Rules - Jun 5th, 2025 7:00 am
What's Behind Cellectar Biosciences' Stock Surge? FDA Update Explained - Jun 4th, 2025 10:35 am
Cellectar Granted U.S. FDA Breakthrough Therapy Designation for Iopofosine I 131 in Waldenstrom Macroglobulinemia (WM) - Jun 4th, 2025 6:05 am
Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies - May 22nd, 2025 7:36 am
4 Medical Product Stocks to Watch From a Challenging Industry - May 21st, 2025 9:37 am
Cellectar Biosciences Inc (CLRB) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - May 14th, 2025 1:07 am
Cellectar Biosciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update - May 13th, 2025 5:05 am
Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Tuesday, May 13, 2025 - May 7th, 2025 6:05 am
Cellectar Announces Plan to Explore Strategic Alternatives - Apr 30th, 2025 6:05 am
4 Medical Product Stocks to Buy From a Challenging Industry - Apr 17th, 2025 6:52 am
Is Cellectar Biosciences (CLRB) Stock Outpacing Its Medical Peers This Year? - Mar 18th, 2025 7:40 am
Cellectar Biosciences Inc (CLRB) Q4 2024 Earnings Call Highlights: Strategic Restructuring and ... - Mar 14th, 2025 1:04 am